INS and Hyperglycemia: Body weight gain and moderate hyperglycemia are observed in the adaptive phase (1–7 weeks of consuming a HFD) followed by a plateau stage (8–16 weeks of consuming a HFD), but other important disease conditions, such as insulin resistance, inflammation, and tissue oxidative stress, progressively worsen [44, 45].